These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11407134)

  • 21. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy switching in patients receiving long-acting opioids.
    Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
    Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal fentanyl for chronic pain.
    Pasero CL; McCaffery M
    Am J Nurs; 1997 Nov; 97(11):17-8. PubMed ID: 9372703
    [No Abstract]   [Full Text] [Related]  

  • 25. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
    Payne R; Mathias SD; Pasta DJ; Wanke LA; Williams R; Mahmoud R
    J Clin Oncol; 1998 Apr; 16(4):1588-93. PubMed ID: 9552070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1997-2000. PubMed ID: 16282744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost-effective analysis of rotation from sustained-release morphine tablet to transdermal fentanyl of matrix type or sustained-release oxycodone tablet].
    Ise Y; Wako T; Miura Y; Katayama S; Shimizu H
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2599-603. PubMed ID: 20009462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of transdermal fentanyl for cancer pain management.
    Kaiko RF
    Am Fam Physician; 1993 Mar; 47(4):729-30. PubMed ID: 8438673
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of postoperative pain management using two patient-controlled analgesia methods: nursing perspective.
    Lindley P; Pestano CR; Gargiulo K
    J Adv Nurs; 2009 Jul; 65(7):1370-80. PubMed ID: 19456995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withdrawal symptoms during chronic transdermal fentanyl administration managed with oral methadone.
    Ripamonti C; Campa T; De Conno F
    J Pain Symptom Manage; 2004 Mar; 27(3):191-4. PubMed ID: 15010096
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of transdermal fentanyl in pediatric oncology palliative care.
    Noyes M; Irving H
    Am J Hosp Palliat Care; 2001; 18(6):411-6. PubMed ID: 11712724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Danish Medicines Agency should reconsider the criteria of generic substitution between fentanyl depot patches].
    Christrup LL; Jensen NH; Jonsson T; Sjøgren P; Steffansen B
    Ugeskr Laeger; 2009 Oct; 171(44):3215; author reply 3215. PubMed ID: 19866512
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rejoiner to debate].
    Christrup LL; Jensen NH; Jonsson T; Sjøgren P
    Ugeskr Laeger; 2009 Nov; 171(49):3637; author reply 3637. PubMed ID: 19967831
    [No Abstract]   [Full Text] [Related]  

  • 36. [Transdermal fentanyl].
    Lossignol D; Sternon J
    Rev Med Brux; 1998 Apr; 19(2):83-6. PubMed ID: 9643088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pitfall to avoid when starting a patient on transdermal fentanyl.
    Low JA; Chye R
    Aust Fam Physician; 2000 Dec; 29(12):1173-5. PubMed ID: 11140227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transdermal route as an alternative to oral administration of opioids in cancer pain].
    Burza M; Ginobbi P; Fusco G; Laurenzi L; Tirelli W; Arcuri E
    Clin Ter; 1998; 149(4):277-80. PubMed ID: 9866889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics and clinical efficacy of fentanyl iontophoretic transdermal system for post-operative pain in hospitalized patients.
    Skledar SJ; Lachell CM; Chelly JE
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1925-35. PubMed ID: 26565744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses.
    Svendsen K; Borchgrevink P; Fredheim O; Hamunen K; Mellbye A; Dale O
    Palliat Med; 2011 Oct; 25(7):725-32. PubMed ID: 21378066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.